ED ZITRON: Much of the AI labs' commitment total consists of binding obligations that suppliers and lenders are acting on, so it carries real risk
The Gist
Ed Zitron says many of these AI deals are binding contracts, and companies are already borrowing and building for them. That makes them a real risk, not something to dismiss. This is a steelman: each side is reconstructed in its strongest fair form, not endorsed, and no winner is declared.
Conclusion
A substantial part of the AI labs' commitments consists of non-cancellable or take-or-pay contracts that suppliers and lenders are building and financing against, so those commitments carry real legal and financial exposure and cannot be dismissed as unserious; the remaining aggregate should be broken down before it is relied on either way.
Premises
- Unless open-weight demand is shown at a scale comparable to current infrastructure spending, it cannot carry the justification for that spending.
- Non-cancellable compute commitments are binding obligations with real legal and financial consequences, so they cannot be dismissed as unserious on the ground that they are not yet fully funded.
- Real construction and financing are being committed against the labs' obligations, which shows the supply chain does take those commitments seriously.
- The claim that no one takes the commitments seriously needs to identify the parties and commitments meant, because a general version implies something public companies would be expected to disclose.
- Because a large share of the commitments Baker dismissed are take-or-pay contracts that his own standard treats as serious, the dismissal does not hold for that share, and the headline aggregate should be broken down before anyone relies on it.
Assumptions
- The claim does not say every dollar will be paid; it says the obligations bind and are being acted upon.
- Zitron publishes a newsletter with a paid tier focused on AI skepticism and runs a public relations firm; no financial position in the companies discussed was disclosed in these posts.
- Funding status and legal form are distinct; several examples cited are funded deals that Baker also treats as serious.
Analysis
Argument type: Inductive.
Potential Fallacies
- Reliance treated as validation (appeal to others' behavior) (Premise 3) — Suppliers and lenders building and financing show that they believe the commitments are credible. They do not show the commitments are sound or that the labs can pay. Counterparties can be wrong, insulated by guarantees or collateral, or entangled through vendor financing and equity stakes. The behavior fits 'real exposure' better than 'low risk', and the conclusion claims only the former.
- Unquantified generalization (Premise 5 and Conclusion) — 'Substantial part' and 'large share' carry the conclusion, but no figure, denominator or source is given. The claim could be true at 10% or 80% of the total, with very different implications. Existence of binding contracts does not establish their proportion.
- Equivocation between 'binding' and 'serious' (Premise 2 and Conclusion) — 'Serious' can mean legally enforceable, commercially credible, or likely to be performed. A contract can bind and still be renegotiated, settled for less, or uncollectible if the counterparty is weak. Assumption A1 narrows the claim, but the slide persists when the legal sense is used to rebut what may be a credibility claim.
- Argument from silence (Premise 4) — The absence of public-company disclosures that no one takes the commitments seriously is treated as evidence against that claim. Disclosure depends on materiality, aggregation and confidentiality, and the largest labs are private. The demand for specificity is legitimate, but the inference from non-disclosure is weak.
- Possible straw man (Premises 4 and 5) — The opposing view is rendered as 'no one takes the commitments seriously'. Baker may have meant that the headline total overstates what will be funded or spent, a claim that pointing to some funded take-or-pay deals does not refute. This cannot be settled without his own words.
- Irrelevant premise (Premise 1) — P1 concerns whether open-weight demand can justify infrastructure spending. The conclusion concerns whether commitments are binding. The two questions are logically independent, and P1 appears to be carried over from the wider thread.
Counterarguments
These challenges are not ranked.
- Premises 2 and 3 (High impact) — Bindingness is not collectibility. A take-or-pay contract with a counterparty whose revenue is far below its commitments is a claim on an uncertain future. Such contracts are routinely renegotiated or settled for less, as telecom, fiber and energy take-or-pay contracts show. Supplier and lender activity may reflect shared exposure or circular financing, so the headline total can be read as a measure of fragility. That reading is consistent with Baker's skepticism that the headline overstates what will actually be spent.
- Premise 5 and Conclusion (High impact) — A filings-based breakdown could show that the firm, non-cancellable share is small relative to the headline total, with the rest being letters of intent, MOUs, 'up to' frameworks or milestone-gated options. The argument would then reduce to the trivial point that some contracts are binding, and Baker's dismissal would hold for most of the total.
- Premise 3 (Medium impact) — Suppliers may be financially entangled with the labs through equity stakes and vendor financing, or protected by parent guarantees and collateral. Their building is then correlated with the labs' own signaling and is not independent evidence of credit quality.
- Premise 4 (Medium impact) — The leading labs are private and not subject to securities disclosure, and public suppliers report aggregated obligations (such as remaining performance obligations) that mix cancellable and non-cancellable items. Silence therefore says little about whether commitments are taken seriously.
- Conclusion (Medium impact) — The argument demands a breakdown from others but supplies none. Its own standard, that general claims need named parties and amounts, would equally defeat 'a substantial part' and 'a large share'.
- Premise 1 (Low impact) — Spending could be justified by closed-model API revenue, enterprise contracts or inference growth, independent of open-weight demand, so P1 addresses only one narrow justification.
Suggested Improvements
- Quantification — Provide an itemized table of the headline commitments by instrument (take-or-pay, non-cancellable, MOU, letter of intent, option), counterparty, dollar value and funded status. State in advance a threshold for 'substantial' (for example, over a stated percentage of total dollar value). The central claim currently has no number. Itemizing would turn an assertion into a testable claim and would meet the standard the argument sets for its opponent.
- Primary evidence — Cite public-supplier filings (remaining performance obligations, purchase commitments), debt prospectuses and project-finance records that tie specific projects to specific lab obligations. This would support P3 and P5 with documents and show how much of the headline appears in disclosed, firm obligations.
- Binding versus collectible — Address termination-for-convenience, step-down and force-majeure clauses, counterparty credit, parent guarantees and renegotiation history. Frame exposure in probability-weighted terms and not as serious versus unserious. This closes the gap between legal bindingness and economic reality and answers the strongest counterargument directly.
- Representation of the opponent — Quote Baker's actual claim and the standard he applied, and engage the narrower reading that the headline overstates likely spend. The internal critique in P5 is only as good as the accuracy of the paraphrase, and outside readers cannot check it.
- Supplier-reliance inference — Address circular financing and vendor equity stakes, and present reliance as evidence of exposure and interconnection rather than of soundness. This removes the apparent tension with the author's broader skeptical view and makes the inference defensible.
- Scope and structure — Drop P1 or explain its connection to the conclusion. Distinguish public suppliers, where disclosure applies, from private labs, where it does not. This makes the argument self-contained and applies the P4 inference only where it is valid.
Scenario Tests
- Filings and debt documents show that most of the headline total is firm take-or-pay with no termination-for-convenience rights, backed by credit-strong counterparties. (Supports) — The conclusion is vindicated and the dismissal fails for most of the total. Real exposure would be large, and the disaggregation would strengthen the argument.
- Disaggregation shows that binding take-or-pay contracts are a small minority of the total, with the remainder in letters of intent, frameworks and options. (Challenges) — The conclusion shrinks to the trivial claim that some contracts bind. Baker's dismissal would hold for most of the aggregate, and the argument's own method would refute its 'substantial' framing.
- A major lab's funding stalls, and suppliers and lenders renegotiate or restructure the take-or-pay contracts at a steep discount. (Neutral) — The contracts were binding and acted upon, as A1 holds, but not fully paid. The argument's narrow claim survives, while the idea that bindingness equals seriousness weakens.
- Public suppliers report backlog and purchase obligations that closely match the claimed commitments, and no impairments or cancellations are disclosed. (Supports) — This corroborates P3 and P4 with independent documents, though it is stronger for suppliers than for private labs.
- Historical analogs (1990s telecom and fiber, LNG take-or-pay) are used as a base rate. (Neutral) — Suppliers and lenders did build against binding commitments that later proved unpayable. This supports 'real exposure' but cautions that exposure is not performance, so the commitments are real and risky, not safe.
Coherence & Relevance
The core of the argument (P2, P3, P5 and the conclusion) is coherent and appropriately modest. Legal form is separated from funding status, the claim is limited to bindingness and reliance (A1, A3), and the call for disaggregation is even-handed. Coherence is weakened by four things: the orphaned P1; the unquantified 'substantial' and 'large share' on which the conclusion rests; slippage between 'binding', 'credible' and 'collectible'; and dependence on an unquoted opponent and standard that outside readers cannot verify. The argument succeeds as a rebuttal of blanket dismissal and is less successful as a case for large, material exposure. The author's disclosed commercial position (A2) bears on how much weight to give unquantified claims but does not affect the logic.
- Unless open-weight demand is shown at a scale comparable to current infrastructure spending, it cannot carry the justification for that spending. (Weak) — It addresses whether the spending is justified, not whether commitments are binding. It is a carry-over from the broader exchange and does no work in the conclusion.
- Non-cancellable compute commitments are binding obligations with real legal and financial consequences, so they cannot be dismissed as unserious on the ground that they are not yet fully funded. (Strong) — It establishes legal exposure but not the size of the non-cancellable share, nor collectability given termination rights and counterparty credit.
- Real construction and financing are being committed against the labs' obligations, which shows the supply chain does take those commitments seriously. (Strong) — No named projects or lenders are given. Reliance is not independent of circular financing or guarantees, and it shows belief rather than soundness.
- The claim that no one takes the commitments seriously needs to identify the parties and commitments meant, because a general version implies something public companies would be expected to disclose. (Moderate) — The implied second step, that no such disclosure exists, is unstated. The inference applies to listed suppliers but not to private labs.
- Because a large share of the commitments Baker dismissed are take-or-pay contracts that his own standard treats as serious, the dismissal does not hold for that share, and the headline aggregate should be broken down before anyone relies on it. (Strong) — 'Large share' is unquantified, and Baker's standard and exact claim are not quoted. It rebuts the dismissal but does not independently prove the positive case.